AI Article Synopsis

  • Gorlin syndrome (GS) is a rare genetic condition that leads to an increased lifetime risk of basal cell carcinomas (BCCs), skeletal anomalies (SAs), and other tumors; understanding patient characteristics can help predict disease severity.
  • Data from 248 GS patients was analyzed to investigate the relationship between clinical features and disease burden, revealing significant correlations between SAs and increased occurrences of BCCs and other neoplasms.
  • Results indicate that patients with SAs face a higher risk of severe BCCs and other tumors, suggesting the need for more intensive and continuous medical monitoring for these individuals.

Article Abstract

Purpose: Gorlin syndrome (GS) is a rare genetic disorder characterized by lifetime risk of basal cell carcinomas (BCCs), skeletal anomalies (SAs), and other extracutaneous neoplasms. There is great variation in disease severity, and a genotype-phenotype correlation has not been well established. Here, we investigate whether patients' clinical characteristics predict disease severity to inform clinical decision making.

Methods: Data of 248 patients with GS were collected between 2014 and 2021 from three institutions. Multivariable regression analyses were performed to investigate whether clinical characteristics predicted disease burden. Genotype-phenotype correlations were investigated in 40 patients.

Results: Patients with SAs had a mean increase of 120 lifetime BCCs (95% CI, 27.1 to 213) relative to patients without SAs. Those with ≥ 2 SAs had 2.45 increased odds (95% CI, 1.01 to 5.91) of advanced or metastatic BCCs. Moreover, the presence of multiple SAs was associated with 5.00 increased odds of having a keratocystic odontogenic tumor (95% CI, 2.22 to 11.3) and 2.79 increased odds of an ovarian fibroma (95% CI, 1.05 to 7.40). Genotype-phenotype analyses showed that missense/in-frame mutations were more likely to be hereditary compared with severe deleterious mutation types (100% 27%; = .004). In addition, heat map visualization illustrated that those with more deleterious variants, like large deletions, trended toward increased burden of SAs and BCCs per year.

Conclusion: GS patients with SAs may be at greater risk for developing more numerous and severe BCCs and other neoplastic growths including keratocystic odontogenic tumors and ovarian fibromas. Current clinical guidelines suggest yearly follow-up in individuals with GS. Since SAs are usually recognized at the time of diagnosis, our results suggest that more vigilant lifetime multidisciplinary surveillance should be considered for these patients starting in childhood.

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.21.02385DOI Listing

Publication Analysis

Top Keywords

clinical characteristics
12
disease severity
12
patients sas
12
increased odds
12
gorlin syndrome
8
genotype-phenotype correlations
8
sas
8
keratocystic odontogenic
8
clinical
5
bccs
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!